Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of the National Cancer Institute
|
February 14, 2008
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry, William H Westra, Sigui Li, et al.
Head & Neck
|
August 10, 2020
Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation
Derek K Smith, Anthony Cmelak, Ken Niermann, et al.
Medical Physics
|
September 8, 2007
Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy
George X Ding, Dennis M Duggan, Bo Lu, et al.
Head & Neck
|
December 1, 2011
Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health
Emily Cooperstein, Jill Gilbert, Joel B Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615
K Thomas Robbins, Parvesh Kumar, Jonathan Harris, et al.
Cancer
|
May 20, 2008
Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
Jill Gilbert, Anthony Cmelak, Yu Shyr, et al.
Oral Oncology
|
December 26, 2015
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma
Christine H Chung, Michelle A Rudek, Hyunseok Kang, et al.
Journal of Neurosurgery
|
March 29, 2024
Benefits of stereotactic radiosurgical anterior capsulotomy for obsessive-compulsive disorder: a meta-analysis
Rishabh Gupta, Jeffrey W Chen, Natasha C Hughes, et al.
The Lancet. Oncology
|
January 19, 2015
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
Jordi Giralt, Jose Trigo, Sandra Nuyts, et al.
American Journal of Otolaryngology
|
February 7, 2022
In reply to: Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence
Madelyn N Stevens, Ankita Patro, Bushra Rahman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of the National Cancer Institute
|
February 14, 2008
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry, William H Westra, Sigui Li, et al.
Head & Neck
|
August 10, 2020
Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation
Derek K Smith, Anthony Cmelak, Ken Niermann, et al.
Medical Physics
|
September 8, 2007
Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy
George X Ding, Dennis M Duggan, Bo Lu, et al.
Head & Neck
|
December 1, 2011
Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health
Emily Cooperstein, Jill Gilbert, Joel B Epstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615
K Thomas Robbins, Parvesh Kumar, Jonathan Harris, et al.
Cancer
|
May 20, 2008
Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
Jill Gilbert, Anthony Cmelak, Yu Shyr, et al.
Oral Oncology
|
December 26, 2015
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma
Christine H Chung, Michelle A Rudek, Hyunseok Kang, et al.
Journal of Neurosurgery
|
March 29, 2024
Benefits of stereotactic radiosurgical anterior capsulotomy for obsessive-compulsive disorder: a meta-analysis
Rishabh Gupta, Jeffrey W Chen, Natasha C Hughes, et al.
The Lancet. Oncology
|
January 19, 2015
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
Jordi Giralt, Jose Trigo, Sandra Nuyts, et al.
American Journal of Otolaryngology
|
February 7, 2022
In reply to: Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence
Madelyn N Stevens, Ankita Patro, Bushra Rahman, et al.
Page
of 3